Prostate cancer: Current evidence weighs against population screening

CA Cancer Journal for Clinicians

Volumn 59, Issue 4, 2009, Pages 220-224

  Boyle, Peter ^a   Brawley, Otis W ^b  

^a INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

^b AMERICAN CANCER SOCIETY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN DERIVATIVE; PROSTATE SPECIFIC ANTIGEN;

BLOOD SAMPLING; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SCREENING; CARDIOVASCULAR DISEASE; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CLINICAL PROTOCOL; COLORECTAL CANCER; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; EDITORIAL; EVIDENCE BASED PRACTICE; HEALTH CARE COST; HEALTH PROGRAM; HORMONAL THERAPY; HOSPITAL; HUMAN; IMPOTENCE; LABORATORY TEST; LUNG CANCER; MEDICAL SOCIETY; MORBIDITY; OVARY CANCER; POPULATION BASED CASE CONTROL STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; RISK FACTOR; RISK REDUCTION; STROKE; URINE INCONTINENCE;

AGED; AGED, 80 AND OVER; EVIDENCE-BASED MEDICINE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 67651103001     PISSN: 00079235     EISSN: 15424863     Source Type: Journal    
DOI: 10.3322/caac.20025     Document Type: Editorial

References (20)

1. Boyle P, Levin B, eds. World Cancer Report 2008. Lyon, France: IARC Press; 2008.
2. Walter LC, Bertenthal D, Lindquist K, Konety BR. PSA screening among elderly men with limited life expectancies. JAMA. 2006;296: 2336-2342.
3. Vessella RL, Lange PH. Issues in the assessment of PSA immunoassays. Urol Clin North Am. 1993;20:607-619.
4. Catalona WJ, Smith DS, Ratliff TL, et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med. 1991;324:1156-1161.
5. Labrie F, Dupont A, Candas B, et al. Decrease of prostate cancer death by screening: first data from the Quebec prospective and randomized study [abstract]. Proc Am Soc Clin Oncol. 1998;17: Page. Abstract 4.
6. Labrie F, Candas B, Dupont A, et al. Screening decreases prostate cancer death: first analysis of the 1988 Quebec prospective randomized controlled trial. Prostate. 1999;38:83-91.
7. Boyle P. Screening for prostate cancer: have you had your cholesterol measured? BJU Int. 2003;92:191-199.
8. DeMets DL. Statistical issues in interpreting clinical trials. J Intern Med. 2004;255:529-537.
9. Sandblom G, Varenhorst E, Löfman O, et al. Clinical consequences of screening for prostate cancer: 15 years follow-up of a randomised controlled trial in Sweden. Eur Urol. 2004;46:717-723.
10. Ilic D, O'Connor D, Green S, Wilt T. Screening for prostate cancer. Cochrane Database Syst Rev. 2006;3:CD004720.
11. Andriole GL, Grubb RL, Buys SS, et al. Mortality results from a randomized prostate-cancer screening trial. N Engl J Med. 2009; 360:1310-1319.
12. Schroeder FH, Hugosson J, Roobol MJ, et al. Screening and prostate-cancer mortality in a European randomised trial. N Engl J Med. 2009;360:1320-1328.
13. Zelen M. Are primary cancer prevention trials feasible? J Natl Cancer Inst. 1988;80:1442-1444.
14. Penson DR, McLerran D, Feng Z, et al. 5-year urinary and sexual outcomes after radical prostatectomy: results from the Prostate Cancer Outcomes Study. J Urol. 2008;179(5 suppl):S40-S44.
15. Llorente MD, Burke M, Gregory GR, et al. Prostate cancer: a significant risk factor for late-life suicide. Am J Geriatr Psychiatry. 2005; 13:195-201.
16. Himmelstein DU, Warren E, Thorne D, Woolhandler S. Illness and injury as contributors to bankruptcy. Health Aff (Millwood). 2005; (suppl Web Exclusives):W5-63-W5-73.
17. Efstathiou JA, Bae K, Shipley WU, et al. Cardiovascular mortality after androgen deprivation therapy for locally advanced prostate cancer: RTOG 85-31. J Clin Oncol. 2009;27:92-99.
18. Seidman H, Mushinski MH, Gelb SK, Silverberg E. Probabilities of eventually developing or dying of cancer-United States, 1985. CA Cancer J Clin. 1985;35:36-56.
19. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43-66.
20. Smith RA, Cokkinides V, Brawley OW. Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin. 2009;59:27-41.